Lenalidomide Supplier-Buyer Network — Trade Flow Analysis

Name: Lenalidomide Supplier-Buyer Trade Network Dataset — 237+ Indian Exporters, 21+ Importers, 122+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Lenalidomide supplier network, Lenalidomide buyers, pharmaceutical export India, Lenalidomide trade data

TransData Nexus

Lenalidomide

India Pharmaceutical Trade Intelligence

$883.1M237 Suppliers122 CountriesHS 30049049

ExportsIndia → UNITED STATES96.7%India → JAPAN0.6%

ImportsUNITED STATES → India$1.6M SWITZERLAND → India$1.3M

#1 Supplier: SUN PHARMACEUTICAL #1 Buyer: SUN PHARMACEUTICAL

Who Supplies Lenalidomide? Top Manufacturers & Buyers 2026 — SUN PHARMACEUTICAL INDUSTRIES LIMITED Leads | TransData Nexus | TransData Nexus

1SUN PHARMACEUTICAL INDUSTRIES LIMITED

SUN PHARMACEUTICAL INDUSTRIES LIMITED is the first-largest Lenalidomide exporter from India, with a market share of 53.8% and a total export value of $475.2M across 144 shipments. Their average shipment value of $3.3M is above the market average of $324.2K, suggesting premium or bulk contract pricing.

SUN PHARMACEUTICAL INDUSTRIES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• SUN PHARMACEUTICAL INDUSTRIES,INC.. — $190.9M across 58 shipments (40.2% of this supplier's total exports)

• SUN PHARMACEUTICAL INDUSTRIES,INC.. — $126.6M across 38 shipments (26.6% of this supplier's total exports)

• SUN PHARMACEUTICAL INDUSTRIES,INC.. — $100.8M across 31 shipments (21.2% of this supplier's total exports)

• SUN PHARMACEUTICAL INDUSTRIES,INC.. — $49.4M across 15 shipments (10.4% of this supplier's total exports)

• 2 INDEPENDENCE WAY P — $7.4M across 2 shipments (1.6% of this supplier's total exports)

Key Insight: SUN PHARMACEUTICAL INDUSTRIES LIMITED's per-shipment value of $3.3M is 918% above the market average of $324.2K, consistent with large-order contracts or value-added formulations.

2EUGIA PHARMA SPECIALITIES LIMITED

EUGIA PHARMA SPECIALITIES LIMITED is the second-largest Lenalidomide exporter from India, with a market share of 19.4% and a total export value of $171.3M across 189 shipments. Their average shipment value of $906.2K is above the market average of $324.2K, suggesting premium or bulk contract pricing.

EUGIA PHARMA SPECIALITIES LIMITED serves 5 named buyers in our database. AUROBINDO PHARMA USA INC is the dominant customer, accounting for 67.0% of this supplier's tracked business. Top customers include:

• AUROBINDO PHARMA USA INC — $114.8M across 127 shipments (67.0% of this supplier's total exports)

• AUROBINDO PHARMA USA INC — $52.2M across 58 shipments (30.5% of this supplier's total exports)

• AUROBINDO PHARMA USA INC — $3.6M across 4 shipments (2.1% of this supplier's total exports)

• INTER PHARMA S.A.L,, — $371.4K across 0 shipments (0.2% of this supplier's total exports)

• EUGIA PHARMA MALTA L — $331.2K across 0 shipments (0.2% of this supplier's total exports)

Key Insight: EUGIA PHARMA SPECIALITIES LIMITED's per-shipment value of $906.2K is 180% above the market average of $324.2K, consistent with large-order contracts or value-added formulations.

3DR REDDYS LABORATORIES LIMITED

DR REDDYS LABORATORIES LIMITED is the third-largest Lenalidomide exporter from India, with a market share of 14.8% and a total export value of $130.7M across 4 shipments. Their average shipment value of $32.7M is above the market average of $324.2K, suggesting premium or bulk contract pricing.

DR REDDYS LABORATORIES LIMITED serves 4 named buyers in our database. DR REDDYS LABORATORI is the dominant customer, accounting for 99.8% of this supplier's tracked business. Top customers include:

• DR REDDYS LABORATORI — $130.5M across 4 shipments (99.8% of this supplier's total exports)

• Dr Reddy s Laborator — $109.6K across 0 shipments (0.1% of this supplier's total exports)

• PHARMACIE CENTRALE D — $54.2K across 0 shipments (0.0% of this supplier's total exports)

• DR REDDYS LABORATORI — $45.4K across 0 shipments (0.0% of this supplier's total exports)

Key Insight: DR REDDYS LABORATORIES LIMITED's per-shipment value of $32.7M is 9980% above the market average of $324.2K, consistent with large-order contracts or value-added formulations.

4CIPLA LIMITED

CIPLA LIMITED is the fourth-largest Lenalidomide exporter from India, with a market share of 9.0% and a total export value of $79.8M across 42 shipments. Their average shipment value of $1.9M is above the market average of $324.2K, suggesting premium or bulk contract pricing.

CIPLA LIMITED serves 5 named buyers in our database. CIPLA USA INC UPS SUPPLY CHAIN SOL is the dominant customer, accounting for 96.5% of this supplier's tracked business. Top customers include:

• CIPLA USA INC UPS SUPPLY CHAIN SOL — $77.0M across 41 shipments (96.5% of this supplier's total exports)

• CIPLA COLOMBIA SAS Y O DEPOSITO UPS — $1.3M across 1 shipments (1.6% of this supplier's total exports)

• CIPLA COLOMBIA SAS — $929.7K across 0 shipments (1.2% of this supplier's total exports)

• MEDPRO PHARMACEUTICA — $361.8K across 0 shipments (0.5% of this supplier's total exports)

• MEDPRO PHARMACEUTICA — $238.0K across 0 shipments (0.3% of this supplier's total exports)

Key Insight: CIPLA LIMITED's per-shipment value of $1.9M is 486% above the market average of $324.2K, consistent with large-order contracts or value-added formulations.

5HETERO LABS LIMITED

HETERO LABS LIMITED is the fifth-largest Lenalidomide exporter from India, with a market share of 0.6% and a total export value of $5.6M across 23 shipments. Their average shipment value of $241.9K is below the market average of $324.2K, reflecting a high-volume, competitive pricing strategy.

HETERO LABS LIMITED serves 5 named buyers in our database. XXC (XXNG XXNG)XXO XXD is the dominant customer, accounting for 99.4% of this supplier's tracked business. Top customers include:

• XXC (XXNG XXNG)XXO XXD — $5.5M across 23 shipments (99.4% of this supplier's total exports)

• XXVENXXHARXX DRXXRL — $15.0K across 0 shipments (0.3% of this supplier's total exports)

• XXVENXXHARXX HOXXURA — $9.5K across 0 shipments (0.2% of this supplier's total exports)

• XXVENXXHARXX ELXXALV — $5.3K across 0 shipments (0.1% of this supplier's total exports)

• XXAROXXPHAXXA BXX — $5.1K across 0 shipments (0.1% of this supplier's total exports)

Key Insight: HETERO LABS LIMITED operates with high shipment frequency (23 shipments) at a per-shipment value of $241.9K, indicating a broad distribution network with many smaller, regular orders.

6RELIANCE LIFE SCIENCES PRIVATE LIMITED

RELIANCE LIFE SCIENCES PRIVATE LIMITED is the fifth-largest Lenalidomide exporter from India, with a market share of 0.4% and a total export value of $3.7M across 281 shipments. Their average shipment value of $13.1K is below the market average of $324.2K, reflecting a high-volume, competitive pricing strategy.

RELIANCE LIFE SCIENCES PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• PHARMIS SARL — $1.1M across 83 shipments (29.7% of this supplier's total exports)

• BROCACEF HEALTHCARE LOGISTICS BV — $1.1M across 81 shipments (28.9% of this supplier's total exports)

• BROCACEF HEALTHCARE LOGISTICS BV — $701.9K across 53 shipments (19.0% of this supplier's total exports)

• TURGUT ILACLARI A S — $422.6K across 32 shipments (11.4% of this supplier's total exports)

• DHL DIDCOT — $404.8K across 31 shipments (11.0% of this supplier's total exports)

Key Insight: RELIANCE LIFE SCIENCES PRIVATE LIMITED operates with high shipment frequency (281 shipments) at a per-shipment value of $13.1K, indicating a broad distribution network with many smaller, regular orders.

1United States

United States ranks as the first-largest destination for Lenalidomide imports from India, with a total trade value of $853.7M across 79 shipments — representing a 96.7% share of all Lenalidomide exports. The average shipment value of $10.8M is above the global average of $324.2K, indicating high-value procurement contracts or branded formulations. This market is served by 7 tracked buyers.

Named Lenalidomide importers in United States: SUN PHARMACEUTICAL INDUSTRIES,INC. is the largest buyer, accounting for 22.4% ($190.9M) of this market's total imports.

• SUN PHARMACEUTICAL INDUSTRIES,INC. — $190.9M (22.4% of United States's total)

• SUN PHARMACEUTICAL INDUSTRIESINC. — $126.6M (14.8% of United States's total)

• AUROBINDO PHARMA USA., INC, — $114.8M (13.4% of United States's total)

Key Insight: United States's per-shipment average of $10.8M (3233% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

United States is a key market for Lenalidomide imports from India.

Primary Market

Secondary Market

2Japan

Japan ranks as the second-largest destination for Lenalidomide imports from India, with a total trade value of $5.5M across 2 shipments — representing a 0.6% share of all Lenalidomide exports. The average shipment value of $2.8M is above the global average of $324.2K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Lenalidomide importers in Japan: XXC (XXNG XXNG)XXO XXD is the largest buyer, accounting for 100.0% ($5.5M) of this market's total imports.

• XXC (XXNG XXNG)XXO XXD — $5.5M (100.0% of Japan's total)

Key Insight: Japan's per-shipment average of $2.8M (753% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Japan is a key market for Lenalidomide imports from India.

Primary Market

Secondary Market

3Netherlands

Netherlands ranks as the third-largest destination for Lenalidomide imports from India, with a total trade value of $3.8M across 85 shipments — representing a 0.4% share of all Lenalidomide exports. The average shipment value of $45.3K is below the global average of $324.2K, consistent with generic/API volume purchasing. This market is served by 2 tracked buyers.

Named Lenalidomide importers in Netherlands: BROCACEF NL HUB is the largest buyer, accounting for 50.9% ($2.0M) of this market's total imports.

• BROCACEF NL HUB — $2.0M (50.9% of Netherlands's total)

• BROCACEF HEALTHCARE LOGISTICS BV — $1.1M (27.8% of Netherlands's total)

Key Insight: Netherlands receives frequent, smaller shipments of Lenalidomide — typical of markets with distributed retail pharmacy or hospital networks sourcing generics at volume.

Netherlands is a key market for Lenalidomide imports from India.

Primary Market

Secondary Market

4Canada

Canada ranks as the fourth-largest destination for Lenalidomide imports from India, with a total trade value of $3.8M across 8 shipments — representing a 0.4% share of all Lenalidomide exports. The average shipment value of $471.8K is above the global average of $324.2K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.

Named Lenalidomide importers in Canada: TARO PHARMACEUTICALS INC., is the largest buyer, accounting for 25.6% ($966.5K) of this market's total imports.

• TARO PHARMACEUTICALS INC., — $966.5K (25.6% of Canada's total)

• TARO PHARMACEUTICALS INC — $966.0K (25.6% of Canada's total)

• TARO PHARMACEUTICALS INC. — $949.1K (25.1% of Canada's total)

Key Insight: Canada's per-shipment average of $471.8K (46% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Canada is a key market for Lenalidomide imports from India.

Primary Market

Secondary Market

5Colombia

Colombia ranks as the fifth-largest destination for Lenalidomide imports from India, with a total trade value of $3.1M across 3 shipments — representing a 0.4% share of all Lenalidomide exports. The average shipment value of $1.0M is above the global average of $324.2K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Lenalidomide importers in Colombia: CIPLA COLOMBIA SAS Y O DEPOSITO UPS is the largest buyer, accounting for 39.9% ($1.3M) of this market's total imports.

• CIPLA COLOMBIA SAS Y O DEPOSITO UPS — $1.3M (39.9% of Colombia's total)

Key Insight: Colombia's per-shipment average of $1.0M (223% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Colombia is a key market for Lenalidomide imports from India.

Primary Market

Secondary Market

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Lenalidomide.
2.Flow Mapping: 237 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 2,724 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 122 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

2,724 Verified Shipments

237 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Lenalidomide

Lenalidomide

Who Supplies Lenalidomide? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Market Intelligence

Official References & Regulatory Resources

Who Supplies Lenalidomide? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Lenalidomide Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1SUN PHARMACEUTICAL INDUSTRIES LIMITED

2EUGIA PHARMA SPECIALITIES LIMITED

3DR REDDYS LABORATORIES LIMITED

4CIPLA LIMITED

5HETERO LABS LIMITED

6RELIANCE LIFE SCIENCES PRIVATE LIMITED

From Indian Factories to Global Pharmacies — How Lenalidomide Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Lenalidomide Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1United States

2Japan

3Netherlands

4Canada

5Colombia

People Also Ask — Lenalidomide Supplier & Trade Network

Lenalidomide Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology